EverSonix
ADVANCED PAIN MANAGEMENT: NO SURGERY. NO OPIOIDS. JUST RESULTS.
EverSonix
has created a novel medical device, providing advanced pain treatment for upwards of 30 million Americans living in pain caused by damage or dysfunction in the nervous system. Our device uses ultrasound-based technology to disrupt pain signals en route to the brain. With just a 3-minute ultrasound treatment, LoFUS has been shown to provide up to 30 days of pain relief in animal models. LoFUS will provide patients with a cost-effective solution without the risk of opioid addiction or the need for needles, while creating a repeatable revenue stream for hospitals.
~77 million Americans seek treatment for lower back pain; 10 million people have high-impact sciatic pain.
52.4 cases/1,000 persons/year, chronic pain incidence is greater than that of diabetes, depression, and hypertension.
62% with no relief, the incidence of people with chronic pain in 2019 reported no relief within a year.
High Cost: >$500B in healthcare costs/lost wages per year due to chronic pain.
The Problem
Existing pain solutions fall short, leaving 40% of patients with insufficient relief and major side effects. Currently, the best solutions available involve opioids, injections, and/or invasive medical devices/procedures. What if we had a repeatable solution to disrupt pain signals without the need for needles, drugs, incisions, and with no side effects? It is time for a novel approach to pain therapy.
Our Solution
LoFUS is a focused ultrasound device that can successfully modulate or “turn down” the pain signal at the dorsal root ganglion (DRG) without surgery, injections, or drugs. It is a proprietary solution with an external applicator that delivers ultrasound waves at varying depths based on an individual’s personal anatomy. LoFUS is a novel non-surgical way to disrupt spinal pain signals without damaging tissue or nerves.